FR2010678A1 - Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis - Google Patents

Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis

Info

Publication number
FR2010678A1
FR2010678A1 FR6919318A FR6919318A FR2010678A1 FR 2010678 A1 FR2010678 A1 FR 2010678A1 FR 6919318 A FR6919318 A FR 6919318A FR 6919318 A FR6919318 A FR 6919318A FR 2010678 A1 FR2010678 A1 FR 2010678A1
Authority
FR
France
Prior art keywords
hepatitis
carre
disease
leptospirosis
active against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6919318A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Publication of FR2010678A1 publication Critical patent/FR2010678A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR6919318A 1968-06-11 1969-06-11 Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis Withdrawn FR2010678A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU56248 1968-06-11

Publications (1)

Publication Number Publication Date
FR2010678A1 true FR2010678A1 (en) 1970-02-20

Family

ID=19725636

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6919318A Withdrawn FR2010678A1 (en) 1968-06-11 1969-06-11 Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis

Country Status (2)

Country Link
FR (1) FR2010678A1 (enrdf_load_stackoverflow)
LU (1) LU56248A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330409A1 (fr) * 1975-11-05 1977-06-03 Pasteur Institut Procede de preparation d'un nouveau vaccin antileptospirose monovalent, et vaccin ainsi obtenu
FR2751227A1 (fr) * 1996-07-19 1998-01-23 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634903A (enrdf_load_stackoverflow) *

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE634903A (enrdf_load_stackoverflow) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2330409A1 (fr) * 1975-11-05 1977-06-03 Pasteur Institut Procede de preparation d'un nouveau vaccin antileptospirose monovalent, et vaccin ainsi obtenu
FR2751227A1 (fr) * 1996-07-19 1998-01-23 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
WO1998003199A1 (fr) * 1996-07-19 1998-01-29 Merial Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
US6228846B1 (en) 1996-07-19 2001-05-08 Merial Polynucleotide vaccine formula against canine pathologies
AU733563B2 (en) * 1996-07-19 2001-05-17 Merial Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
US6586412B2 (en) 1996-07-19 2003-07-01 Merial Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies

Also Published As

Publication number Publication date
LU56248A1 (enrdf_load_stackoverflow) 1970-01-15

Similar Documents

Publication Publication Date Title
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
ES402773A1 (es) Dispositivo para la administracion de sustancias activas a animales.
GB1059676A (en) Process for stabilising biologically active proteinaceous materials
SE7512828L (sv) Calicivirusvaccin
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
FR2010678A1 (en) Stable polyvalent vaccine for treatment of dogs - active against Carre's disease, hepatitis and leptospirosis
SE7602871L (sv) Vaccin for aktiv immunisering
ES2063897T3 (es) Vacuna contra el virus del colera porcino y diagnostico.
FI890116A0 (fi) Icke-reverterande rna-virus.
IT1023004B (it) Metodo per preparare vaccine per uso veterinario per la enterite impettiva dei feilini la rinotracheite la mammalitet povina herpes i virus la mammalite povina herpes i virus della leucemia del gatto ed i picormavirus dei felini
FR1603312A (en) Injectable vaccine prepns
DK506979A (da) Vaccine mod infektioes katte-peritonitis og fremgangsmaade til dens fremstilling
van der Noordaa et al. Primary vaccination with an attenuated strain of vaccinia virus
GB1212886A (en) Equine vaccine and vaccination treatment
GB953992A (en) Vaccine products and method of preparing same
FR2290220A2 (fr) Nouveau vaccin antirabique
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.
RO76563A2 (ro) Procedeu de stabilizare a unui vaccin antiherpetic
Glaner et al. 30-Year record of swine fever vaccine production in Insel Riems.
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB949400A (en) Poliomyelitis vaccines
NL170956C (nl) Werkwijze ter bereiding van farmaceutische preparaten met anticonvulsieve werking op basis van s-triazoloŸ4,3-aŸŸ1,4Ÿbenzodiazepinederivaten, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen geschikt voor gebruik bij deze werkwijze.
FR2012406A1 (en) Swine fever vaccine - freeze-dried and contg stabiliser
GB1284703A (en) Anhydrous smallpox vaccine and process for producing it

Legal Events

Date Code Title Description
ST Notification of lapse